We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 318 results
  1. Clinical characteristics and outcomes in risk-stratified patients with smoldering multiple myeloma: data from the Czech Republic Registry of Monoclonal Gammopathies

    Smoldering multiple myeloma (SMM) is an asymptomatic precursor to active multiple myeloma (MM). The aim of this study was to report clinical...

    Viera Sandecka, Tereza Popkova, ... Ivan Spicka in Blood Cancer Journal
    Article Open access 27 September 2023
  2. Immunophenotypic assessment of clonal plasma cells and B-cells in bone marrow and blood in the diagnostic classification of early stage monoclonal gammopathies: an iSTOPMM study

    Monoclonal gammopathy of undetermined significance (MGUS) is the earliest discernible stage of multiple myeloma (MM) and Waldenström’s...

    Oihane Pérez-Escurza, Juan Flores-Montero, ... Alberto Orfao in Blood Cancer Journal
    Article Open access 11 December 2023
  3. Cutaneous manifestations of monoclonal gammopathy

    Monoclonal gammopathy associated with dermatological manifestations are a well-recognized complication. These skin disorders can be associated with...

    Jean-Sebastien Claveau, David A. Wetter, Shaji Kumar in Blood Cancer Journal
    Article Open access 11 April 2022
  4. Therapeutic Monoclonal Antibody Therapies in Chronic Autoimmune Demyelinating Neuropathies

    Autoimmune diseases of the peripheral nervous system have so far been treated mainly with exogenous high-dose intravenous immunoglobulins (IVIg),...

    Chiara Briani, Andrea Visentin in Neurotherapeutics
    Article Open access 28 March 2022
  5. MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients

    Immunoenrichment-based matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF-MS), termed MASS-FIX, offers several...

    Patrick W. Mellors, Surendra Dasari, ... Angela Dispenzieri in Blood Cancer Journal
    Article Open access 04 March 2021
  6. Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies

    Monoclonal gammopathies (MG) constitute a spectrum of disorders starting from a monoclonal gammopathy of undetermined significance (MGUS) to active...

    Shaji Kumar, Dirk R. Larson, ... S. Vincent Rajkumar in Blood Cancer Journal
    Article Open access 17 May 2019
  7. Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies

    There is evidence of reduced SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies. We hypothesized that tumor and...

    Luis-Esteban Tamariz-Amador, Anna Martina Battaglia, ... Bruno Paiva in Blood Cancer Journal
    Article Open access 14 December 2021
  8. Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS)

    Monoclonal gammopathy of undetermined significance (MGUS) is rare in young patients (age <40 years at diagnosis), with a prevalence of <0.3%,...

    Li Pang, S. Vincent Rajkumar, ... Shaji Kumar in Blood Cancer Journal
    Article Open access 01 February 2021
  9. Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestry

    Multiple myeloma (MM) is two- to three-fold more common in African Americans (AAs) compared to European Americans (EAs). This striking disparity, one...

    Linda B. Baughn, Kathryn Pearce, ... S. Vincent Rajkumar in Blood Cancer Journal
    Article Open access 10 October 2018
  10. Glomerulonephritis: immunopathogenesis and immunotherapy

    ‘Glomerulonephritis’ (GN) is a term used to describe a group of heterogeneous immune-mediated disorders characterized by inflammation of the...

    Hans-Joachim Anders, A. Richard Kitching, ... Paola Romagnani in Nature Reviews Immunology
    Article 12 January 2023
  11. Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study

    Serum free light chain (FLC) concentration is greatly affected by kidney function. Using a large prospective population-based cohort, we aimed to...

    Thorir Einarsson Long, Olafur Skuli Indridason, ... Sigurdur Yngvi Kristinsson in Blood Cancer Journal
    Article Open access 14 September 2022
  12. Determining hemodilution in diagnostic bone marrow aspirated samples in plasma cell disorders by next-generation flow cytometry: Proposal for a bone marrow quality index

    Hemodilution of bone marrow (BM) aspirates is a limitation of multiparameter flow cytometry (MFC) in plasma cell disorders. There is a need for a...

    Jón Þórir Óskarsson, Sæmundur Rögnvaldsson, ... Sigurdur Yngvi Kristinsson in Blood Cancer Journal
    Article Open access 01 December 2023
  13. Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice

    Background

    We have performed a head to head comparison of all-oral triplet combination of ixazomib, lenalidomide and dexamethasone (IRD) versus...

    Jiri Minarik, Tomas Pika, ... Roman Hajek in BMC Cancer
    Article Open access 15 January 2021
  14. Letter Q

    Quincke’s oedema (angioedema, Quincke disease, Quincke syndrome, Bannister disease, Bannister syndrome, Milton urticaria, Milton-Quincke syndrome) is...
    Michael R. Shurin, Galina V. Shurin, Ken M. Shurin in Basic and Clinical Immunology by Names
    Chapter 2023
  15. Cancer Stem Cell Markers in Haematological Malignancies

    Cancer stem cells (CSCs) are a subgroup of tumour cells with tumorigenic potential due to their ability to transform into tumours through...
    Chapter 2023
  16. Letter W

    Waelsch’s disease (see Reiter’s syndrome Nongonococcal urethritis or Waelsch urethritis) is a part of now a familiar triad—namely, the conjunctiva of...
    Michael R. Shurin, Galina V. Shurin, Ken M. Shurin in Basic and Clinical Immunology by Names
    Chapter 2023
  17. Free Immunoglobulin Light Chains as Criteria of Extracorporeal Hemocorrection in Patients with Monoclonal Gammopathies

    Elimination of free immunoglobulin light chains with the use of EMic2 selective filters was carried out in 12 patients with monoclonal gammopathies...

    N. V. Lyubimova, Yu. S. Timofeeva, ... N. E. Kushlinskii in Bulletin of Experimental Biology and Medicine
    Article 29 August 2017
  18. Molecular signatures of inherited and acquired sporadic late onset nemaline myopathies

    Acquired sporadic late onset nemaline myopathy (SLONM) and inherited nemaline myopathy (iNM) both feature accumulation of nemaline rods in muscle...

    Stefan Nicolau, Aneesha Dasgupta, ... Margherita Milone in Acta Neuropathologica Communications
    Article Open access 26 January 2023
Did you find what you were looking for? Share feedback.